HiFi long-read genomes for difficult-to-detect, clinically relevant variants.
Wolfram Höps1, Marjan M Weiss1, Ronny Derks1
1Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands; Radboudumc Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
American Journal of Human Genetics
|January 14, 2025
Summary
Long-read sequencing (LRS) offers a promising solution for rare disease diagnosis by accurately identifying challenging genetic variants. This technology has the potential to become a primary diagnostic tool, improving rare disease detection rates.
Area of Science:
- Genomics
- Medical Genetics
Background:
- Short-read sequencing is standard for rare disease diagnostics but struggles with complex genomic regions.
- Existing methods often require multiple complementary tests to detect all relevant variants.
Purpose of the Study:
- To evaluate long-read sequencing (LRS) as a potential first-tier diagnostic test for rare diseases.
- To assess LRS accuracy in detecting challenging germline variants missed by short-read sequencing.
Main Methods:
- Performed 30× high-fidelity (HiFi) long-read sequencing on 100 samples with 145 known difficult-to-detect variants.
- Utilized standard variant callers to analyze sequencing data.
- Conducted titration analysis to assess performance at reduced coverage.
Main Results:
- LRS successfully re-identified 83% of variants automatically, including structural variants, indels in homologous regions, and short tandem repeat expansions.
- An additional 10% of variants were visually apparent but not automatically called.
- Systematic challenges were noted for specific variant types, like AG-rich repeat expansions.
- 93% of challenging pathogenic variants were identified, with 90% of variants detectable at 15× coverage.
Conclusions:
- Long-read sequencing demonstrates high accuracy in detecting a wide spectrum of clinically relevant rare disease variants.
- LRS shows potential as a unified, cost-effective diagnostic approach, reducing the need for multiple testing modalities.
- Further optimization is needed for specific complex variant types, but LRS is a significant advancement for rare disease diagnostics.


